Platelet-Leukocyte Aggregates Tissue Factor in Patients With Acute Coronary Syndromes : Expression in Platelets

Peter L. Giesen, Alessandra Balduini, Fabrizio Veglia, Karl Gertow, Paolo Biglioli and Elena Marta Brambilla, Marina Camera, Deborah Colnago, Giancarlo Marenzi, Monica De Metrio, Leukocytes, and Platelet-Leukocyte Aggregates Tissue Factor in Patients With Acute Coronary Syndromes : Expression in Platelets, Print ISSN: 1079-5642. Online ISSN: 1524-4636 Copyright © 2008 American Heart Association, Inc. All rights reserved. Greenville Avenue, Dallas, TX 75231 is published by the American Heart Association, 7272 Arteriosclerosis, Thrombosis, and Vascular Biology doi: 10.1161/ATVBAHA.107.161471 2008; 2008;28:947-953; originally published online February 21, Arterioscler Thromb Vasc Biol. http://atvb.ahajournals.org/content/28/5/947 World Wide Web at: The online version of this article, along with updated information and services, is located on the http://atvb.ahajournals.org/content/suppl/2008/04/18/ATVBAHA.107.161471.DC1.html Data Supplement (unedited) at:

[1]  C. Bauters,et al.  [Pathophysiology of coronary artery disease]. , 2008, La Revue du praticien.

[2]  D. Devine,et al.  Translation of glycoprotein IIIa in stored blood platelets , 2007, Transfusion.

[3]  N. Mackman,et al.  Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis. , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[4]  C. Sáez,et al.  Human platelets synthesize and express functional tissue factor. , 2007, Blood.

[5]  L. Avigliano,et al.  Translational control of the ascorbic acid transporter SVCT2 in human platelets. , 2007, Free radical biology & medicine.

[6]  Nigel Mackman,et al.  Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenecity of human platelets , 2006, The Journal of experimental medicine.

[7]  E. Tremoli,et al.  Human polymorphonuclear leukocytes produce and express functional tissue factor upon stimulation 1 , 2006, Journal of thrombosis and haemostasis : JTH.

[8]  P. Libby,et al.  Platelet Expression Profiling and Clinical Validation of Myeloid-Related Protein-14 as a Novel Determinant of Cardiovascular Events , 2006, Circulation.

[9]  S. Volinia,et al.  Cord blood in vitro expanded CD41+ cells: identification of novel components of megakaryocytopoiesis , 2006, Journal of thrombosis and haemostasis : JTH.

[10]  A. Sacchetti,et al.  De Novo Synthesis of Cyclooxygenase-1 Counteracts the Suppression of Platelet Thromboxane Biosynthesis by Aspirin , 2006, Circulation research.

[11]  A. C. van der Wal,et al.  Tissue factor expression in the morphologic spectrum of vulnerable atherosclerotic plaques. , 2006, Seminars in thrombosis and hemostasis.

[12]  J. Zwaginga,et al.  Leukocyte-platelet aggregates: new particles reflecting and effecting cardiovascular disease , 2005, Thrombosis and Haemostasis.

[13]  P. Savi,et al.  Clopidogrel inhibits platelet-leukocyte adhesion and plateletdependent leukocyte activation , 2005, Thrombosis and Haemostasis.

[14]  C. Weber.  Platelets and chemokines in atherosclerosis: partners in crime. , 2005, Circulation research.

[15]  N. Lakkis,et al.  Reticulated platelets in acute coronary syndrome: a marker of platelet activity. , 2004, Journal of the American College of Cardiology.

[16]  D. Dixon,et al.  Change in protein phenotype without a nucleus: translational control in platelets. , 2004, Seminars in thrombosis and hemostasis.

[17]  Zhiqiang Shen,et al.  Effects of copper-aspirin complex on platelet-neutrophil interactions. , 2004, Acta pharmacologica Sinica.

[18]  E. Tremoli,et al.  Platelet Activation Induces Cell-Surface Immunoreactive Tissue Factor Expression, Which Is Modulated Differently by Antiplatelet Drugs , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[19]  H. Coenraad Hemker,et al.  Calibrated Automated Thrombin Generation Measurement in Clotting Plasma , 2003, Pathophysiology of Haemostasis and Thrombosis.

[20]  K. Preissner,et al.  Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  Andreas Schober,et al.  Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E , 2003, Nature Medicine.

[22]  F. Crea,et al.  Widespread coronary inflammation in unstable angina. , 2003, The New England journal of medicine.

[23]  J. Loscalzo,et al.  Platelet-monocyte aggregates: bridging thrombosis and inflammation. , 2002, Circulation.

[24]  A. Jha,et al.  Increased Platelet Binding to Circulating Monocytes in Acute Coronary Syndromes , 2002, Circulation.

[25]  J. Muller,et al.  Triggers of acute coronary syndromes. , 2002, Progress in cardiovascular diseases.

[26]  Christopher M. Thompson,et al.  Monitoring of platelet function in the setting of glycoprotein IIb/IIIa inhibitor therapy. , 2002, Journal of interventional cardiology.

[27]  F. Siddiqui,et al.  The presence and release of tissue factor from human platelets , 2002, Platelets.

[28]  M. Furman,et al.  Circulating Monocyte-Platelet Aggregates Are a More Sensitive Marker of In Vivo Platelet Activation Than Platelet Surface P-Selectin: Studies in Baboons, Human Coronary Intervention, and Human Acute Myocardial Infarction , 2001, Circulation.

[29]  D. Dixon,et al.  Activated platelets mediate inflammatory signaling by regulated interleukin 1β synthesis , 2001, The Journal of cell biology.

[30]  Y. Nemerson,et al.  Tissue factor, the blood, and the arterial wall. , 2000, Trends in cardiovascular medicine.

[31]  P. Libby,et al.  The stromal cell-derived factor-1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques. , 2000, Circulation research.

[32]  E. Tremoli,et al.  Increased Thrombogenic Potential of Human Monocyte-derived Macrophages Spontaneously Transformed into Foam Cells , 1999, Thrombosis and Haemostasis.

[33]  R. Becker,et al.  Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. , 1998, Journal of the American College of Cardiology.

[34]  I. Tsuji,et al.  Increased plasma tissue factor levels in acute myocardial infarction. , 1997, American heart journal.

[35]  F. Neumann,et al.  Increased neutrophil-platelet adhesion in patients with unstable angina. , 1996, Circulation.

[36]  M. Katoh,et al.  Inhibitory effects of TA-993, a new 1,5-benzothiazepine derivative, on platelet aggregation. , 1996, Circulation research.

[37]  A. Camm,et al.  Increased monocyte tissue factor expression in coronary disease. , 1995, British heart journal.